Tekmira is a leader in the development of therapeutic agents based upon Nobel Prize winning breakthroughs in the field of gene silencing, known as RNA interference (RNAi). Tekmira's lead RNAi product candidates target cancer, Ebola infection, and other indications.
Read more about Tekmira's products here.
Tekmira's 2013 AGM and Proxy Materials are now available on our website.
Site Map Copyright©2012 Tekmira Pharmaceuticals Corp. All rights reserved. See legal terms for use of site.